Brief Report

Discordant noninvasive prenatal testing and cytogenetic results: a study of 109 consecutive cases



Recent published studies have demonstrated the incremental value of the use of cell-free DNA for noninvasive prenatal testing with 100% sensitivity for trisomies 21 and 18 and a specificity of ≥99.7% for both. Data presented by two independent groups suggesting positive results by noninvasive prenatal testing were not confirmed by cytogenetic studies.


Concordance of results among cases with noninvasive prenatal testing referred for cytogenetic prenatal and/or postnatal studies by karyotyping, fluorescence in situ hybridization, and/or oligo–single-nucleotide polymorphism microarray was evaluated for 109 consecutive specimens.


Cytogenetic results were positive for trisomy 21 in 38 of the 41 noninvasive prenatal testing–positive cases (true-positive rate: 93%) and for trisomy 18 in 16 of the 25 noninvasive prenatal testing–positive cases (true-positive rate: 64%). The true-positive rate was only 44% (7/16 cases) for trisomy 13 and 38% (6/16 cases) for sex chromosome aneuploidy.


These findings raise concerns about the limitations of noninvasive prenatal testing and the need for analysis of a larger number of false-positive cases to provide true positive predictive values for noninvasive testing and to search for potential biological or technical causes. Our data suggest the need for a careful interpretation of noninvasive prenatal testing results and cautious transmission of the same to providers and patients.

Genet Med 17 3, 234–236.

  • Subscribe to Genetics in Medicine for full access:



Additional access options:

Already a subscriber?  Log in  now or  Register  for online access.


  1. 1.

    , , , et al.; CARE Study Group. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med 2014;370:799–808.

  2. 2.

    , , , et al. Discordant karyotype results among non-invasive prenatal screening positive cases. In: The Shifting Landscape of Genetic Testing: Approaches and Success Stories, Platform Session, Abstract #19, American Society of Human Genetics 2013 Annual Meeting, Boston, MA, USA, 2013.

  3. 3.

    , , , et al. Non-invasive prenatal screening: a cytogenetic perspective. In: Oral Platform Presentations: Cytogenetics, Abstract #17, American College of Medical Genetics and Genomics 2014 Annual Meeting, Nashville, Tennessee, USA, 2014.

  4. 4.

    , , , . Noninvasive prenatal testing: limitations and unanswered questions. Genet Med 2014;16:281–285.

  5. 5.

    , , . Chromosome Abnormalities and Genetic Counseling. 4th edn. Oxford University Press: New York, 2012.

Download references

Author information


  1. Cytogenetics Laboratory, Quest Diagnostics Nichols Institute, San Juan Capistrano, California, USA

    • Jia-Chi Wang
    • , Trilochan Sahoo
    • , Kimberly A. Kopita
    • , Leslie Ross
    •  & Charles M. Strom
  2. Current affiliation: CombiMatrix, Irvine, California, USA

    • Trilochan Sahoo
  3. Cytogenetics Laboratory, Quest Diagnostics Nichols Institute, Chantilly, Virginia, USA

    • Steven Schonberg
    •  & Kyla Patek


  1. Search for Jia-Chi Wang in:

  2. Search for Trilochan Sahoo in:

  3. Search for Steven Schonberg in:

  4. Search for Kimberly A. Kopita in:

  5. Search for Leslie Ross in:

  6. Search for Kyla Patek in:

  7. Search for Charles M. Strom in:

Corresponding author

Correspondence to Jia-Chi Wang.

Supplementary information

Word documents

  1. 1.

    Supplementary Table S1